Home  |  Investor Relations  |  News  |  Events  |  Clinical Trials  |  Contact Us

Investor Relations — NASDAQ: CYTX

Regenerative medicine holds the potential to transform medicine in the same way that computers changed communication

What's New
May 9, 2012 CEO Q2 Letter Cytori Provides Business Update; Reports First Quarter Results
May 9, 2012 CEO Q2 Letter May 2012 Shareholder Letter
May 9, 2012 Webcast Cytori Therapeutics Q1 Earnings Call
Mar 8, 2012 Webcast Cytori Therapeutics Q4/Year End Results Call



Shareholder Briefcase | Investor Kit | News and Event Alerts
Download Library | RSS News Feeds





PDF May 2012 Shareholder Letter
PDF Q1 2012 Earnings Transcript

Investor Contact:
Tom Baker
Tel: +1.858.875.5258
Email: tbaker@cytori.com


Media Contact:
Megan McCormick
Tel: +1.858.875.5279
Email: mmccormick@cytori.com